| 1. |
Cao Y, Prescott SM. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol, 2002, 190(3): 279-286.
|
| 2. |
Boonyaphiphat P, Thongsuksai P, Sriplung H, et al. Lifestyle habits and genetic susceptibility and the risk of esophageal cancer in the Thai population. Cancer Lett, 2002, 186(2): 193-199.
|
| 3. |
Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A, 1997, 94(7): 3336-3340.
|
| 4. |
Leahy KM, Koki AT, Masferrer JL. Role of cyclooxygenases in angiogenesis. Curr Med Chem, 2000, 7(11): 1163-1170.
|
| 5. |
Sivula A, Buskens CJ, van Rees BP, et al. Prognostic role of cyclooxygenase-2 in neoadjuvant-treated patients with squamous cell carcinoma of the esophagus. Int J Cancer, 2005, 116(6): 903-908.
|
| 6. |
Dixon DA. Regulation of COX-2 expression in human cancers. Prog Exp Tumor Res, 2003, 37: 52-71.
|
| 7. |
Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Bmj, 1997, 315(7109): 629-634.
|
| 8. |
Moons LM, Kuipers EJ, Rygiel AM, et al. COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma. Am J Gastroenterol, 2007, 102(11): 2373-2379.
|
| 9. |
Biramijamal F, Basatvat S, Hossein-Nezhad A, et al. Association of COX-2 promoter polymorphism with gastrointestinal tract cancer in Iran. Biochem Genet, 2010, 48(11-12): 915-923.
|
| 10. |
Hu HM, Kuo CH, Lee CH, et al. Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study. BMC Gastroenterol, 2009, 9: 37.
|
| 11. |
Kristinsson JO, van Westerveld P, te Morsche RH, et al. Cyclooxygenase-2 polymorphisms and the risk of esophageal adeno- or squamous cell carcinoma. World J Gastroenterol, 2009, 15(28): 3493-3497.
|
| 12. |
Upadhyay R, Jain M, Kumar S, et al. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma. Mutat Res, 2009, 663(1-2): 52-59.
|
| 13. |
Zhang X, Miao X, Tan W, et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology, 2005, 129(2): 565-576.
|
| 14. |
Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics, 1992, 48(2): 361-372.
|
| 15. |
Kiritoshi S, Nishikawa T, Sonoda K, et al. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes, 2003, 52(10): 2570-2577.
|
| 16. |
Li M, Gao Y, Li C, et al. Association of COX2 functional polymorphisms and the risk of vitiligo in Chinese populations. J Dermatol Sci, 2009, 53(3): 176-181.
|
